Key Takeaways
- The Trump administration has reached a $129 million settlement with Duke Energy (DUK) to cancel its offshore wind lease in North Carolina, bringing total federal wind exit spending to over $2.5 billion.
- Amazon Australia (AMZN) is facing Federal Court proceedings initiated by the ACCC over allegations of unfair contract terms used to introduce advertising on Prime Video.
- The FDA has approved Arcutis Biotherapeutics' (ARQT) Zoryve cream for plaque psoriasis in children as young as age 2, marking the first non-steroidal PDE4 inhibitor for this age group.
- Morgan Stanley (MS) slashed its Q3 Brent crude forecast to $75/bbl, citing a faster-than-expected return of supply through the Strait of Hormuz following a U.S.-Iran de-escalation.
- UK business confidence fell to 44 in June, missing estimates as manufacturing sentiment collapsed by 10 points amid persistent cost pressures.
U.S. Energy Policy Shifts Toward Nuclear and Gas
The Trump administration has finalized a landmark agreement to pay Duke Energy (DUK) $129 million to voluntarily terminate its offshore wind lease in the Carolina Long Bay area. This settlement marks the fourth major deal in a broader federal strategy to dismantle the offshore wind pipeline established under the previous administration. Officials confirmed that the government has now committed over $2.5 billion to exit these agreements, with the capital being redirected toward nuclear and natural gas projects to ensure grid reliability.
Interior Secretary Doug Burgum stated that the move addresses "national security concerns" and aligns with the administration's Energy Dominance Agenda. Duke Energy (DUK) plans to reinvest the funds into generating capacity across the Carolinas, specifically targeting advanced nuclear technologies and gas-fired plants. This shift follows similar buyouts with Invenergy and TotalEnergies, as the administration pivots away from what it describes as "costly, unreliable" renewable subsidies.
Amazon Faces Regulatory Heat in Australia
The Australian Competition and Consumer Commission (ACCC) has commenced legal action against Amazon Commercial Services Pty Ltd (AMZN), alleging the retail giant used unfair contract terms to force ads onto Prime Video subscribers. The regulator claims that between 2023 and 2025, Amazon (AMZN) unilaterally changed its service terms, requiring users to pay an additional $2.99 per month to maintain an ad-free experience.
The ACCC alleges that more than one million annual subscribers were affected by these terms, which provided no option for pro-rata refunds. Amazon (AMZN) has stated it is reviewing the case in detail and maintains that it has cooperated with the investigation. This case is being closely watched as a major test of Australia's new penalty regime for unfair consumer contracts.
Pharmaceutical and Financial Market Developments
In the healthcare sector, Arcutis Biotherapeutics (ARQT) received FDA approval for its Zoryve (roflumilast) cream 0.3% to treat plaque psoriasis in children aged 2 to 5. The approval expands the drug's existing indication and offers a steroid-free alternative for a vulnerable patient population. Analysts view this as a significant commercial milestone for Arcutis (ARQT), as it remains the only topical PDE4 inhibitor approved for this specific age group.
On the M&A front, BMO Financial Group (BMO) announced a definitive agreement to acquire the capital markets business of Euroz Hartleys Group for approximately $145 million. The acquisition is designed to bolster BMO's leadership in the global metals and mining sector by integrating one of Australia's premier equity distribution platforms. The deal is expected to close in the fourth quarter of 2026, pending shareholder and regulatory approvals.
Global Economic Indicators and Oil Volatility
Economic data from the United Kingdom presented a mixed picture as BRC Shop Price Index inflation held steady at 1.2% in June, slightly below the 1.3% estimate. While food inflation eased to its lowest level since 2025, the Lloyds Business Barometer fell to 44, indicating a sharp decline in business morale. The manufacturing sector was particularly hard hit, with confidence dropping 10 points due to global uncertainty and rising National Insurance costs.
In commodities, Morgan Stanley (MS) significantly revised its oil price outlook, cutting its Q3 Dated Brent forecast by $15 to $75/bbl. The downgrade reflects expectations of a rapid supply recovery as the Strait of Hormuz reopens following diplomatic breakthroughs. The bank predicts that 50% of disrupted production could return by September, potentially flipping the market from a deficit into a surplus by year-end.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.